Literature DB >> 6331466

Positive inotropic effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1 -piperazinyl]-2(1H)-quinolinone (OPC-8212) and mechanism of action in guinea pig ventricular myocardium.

K Takeya, M Yajima, S Kobayashi-Ando, H Ando.   

Abstract

Effects of 3,4-dihydro-6-[4-(3,4- dimethoxybenzoyl )-1-piperazinyl]-2(1H)- qu inolinone ( OPC -8212) on the isolated guinea-pig ventricular myocardium was studied measuring the force of contraction and action potential under various experimental conditions. The positive inotropic effect (PIE) of OPC -8212 was observed at a concentration higher than 10(-5) mol/l. The following circumstantial evidence led to the conclusion that OPC -8212 caused an elevated cyclic AMP level in myocardial cells thereby producing the positive inotropic effect. The positive inotropic effect of OPC -8212 was unaffected by reserpinization, propranolol and cimetidine treatments. OPC -8212 strengthened the slow response of partially depolarized papillary muscle. This suggested an increased calcium influx across myocardial cell membrane. Carbachol inhibited the positive inotropic effect of OPC -8212 on ventricular myocardium. Concentration-effect curves for isoprenaline (isoproterenol) and histamine were shifted to the left but that for dihydro-ouabain was not affected at all by OPC -8212. Rested-state contraction of guinea-pig papillary muscle was strengthened by OPC -8212 the same as dibutyryl cyclic AMP and beta-agonists.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331466

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Effects of OPC-8212, a new positive inotropic agent, on canine ventricular arrhythmias.

Authors:  K Hashimoto; H Mitsuhashi
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

2.  A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group.

Authors: 
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

3.  A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment.

Authors:  M Inoue; M Hori; H Yasuda; T Takishima; T Sugimoto; S Sasayama; T Sakurai; H Nonogi; K Kodama; R Kusukawa
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

4.  Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.

Authors:  S Sasayama; M Inoue; H Asanoi; K Kodama; M Hori; T Sakurai; C Kawai
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.